MARKETING RESEARCH OF THE PHARMACEUTICAL MARKET OF UKRAINE IN THE SEGMENT OF ANTIVIRAL DRUGS FOR SYSTEMIC USE

Анотація

The present paper provides an overview of the domestic pharmaceutical market, in particular, of the J05 ATC group – antiviral drugs for systemic use. Objective – conducting marketing research of the pharmaceutical market of Ukraine in the segment of antiviral drugs for systemic use: structuring data on their assortment, the ratio of imported to domestic drugs, the availability of the assortment, comparison of retail prices, and determination of social and economic affordability. Materials and methods: data from the State Register of Medicines of Ukraine. Analytical techniques involved logical, mathematical, statistical, methodical, and comparative methods. The analysis of Ukraine’s domestic market for antiviral drugs, using the State Register of Medicines, brings forth significant insights. The dataset comprises 277 registered medicines within this category. Acyclovir stands out as the most prevalent. Beyond the domestic landscape, the study delves into the global presence of antiviral drugs, uncovering representation from 18 different countries. Indian-produced drugs dominate this scenario, comprising 44.2% of the total while Ukrainian-produced drugs constitute 19.9%. The study extends its focus to the socioeconomic accessibility within the Ukrainian pharmaceutical market. Noteworthy findings state that drugs from Ukrainian manufacturers are among the most readily available and economically accessible. Conclusion. The conducted study encourages consideration of local drug development initiatives to enhance the affordability and accessibility of antiviral medications for the Ukrainian population.

Класифікація

Ідентифікатори

Схожі роботи